COVID-19

A new experimental vaccine developed by Scripps Research could offer a powerful new way to prevent fentanyl overdoses by stopping the drug before it reaches the brain. Rather than targeting only fentanyl itself, the vaccine trains the immune system …

'This influence distorted the public’s understanding of the most consequential pandemic in a century'

Persistent symptoms after COVID-19 infection continue to affect millions of people worldwide, even as the number of acute infections has declined.

Research highlights fundamental differences between Andes hantavirus and SARS-CoV-2, emphasizing distinct transmission routes and public health implications.

The US government coverup of the origins on the covid virus that hit the world in 2020 was bad enough, but now we know that the CIA itself was involved.

Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to be safe and well tolerated. The vaccine generated immune responses against multiple coronaviruses, including SARS-CoV-2, SAR…

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side-effects.

A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and throat from respiratory viruses has been identified.

Deer keds rely on flight and vision to find a host, but everything changes once they land. After shedding their wings forever, these parasites reduce the activity of key vision-related genes by about half. Scientists believe they are effectively tra…

(MedPage Today) -- The FDA approved the oral antiviral agent ensitrelvir (Xocova) to help prevent COVID-19 in people ages 12 years or older who were exposed to the SARS-CoV-2 virus, drugmaker Shionogi announced. Ensitrelvir is a SARS-CoV-2 main...